Visceral adiposity index is positively associated with blood pressure: A systematic review

PurposeThis systematic review aimed to investigate the association between VAI and blood pressure.MethodsThe study was according to the PRISMA standards and the bibliographic search in the PubMed, EMBASE and Cochrane Library databases.ResultsThis review included 32 articles, with 60,482 individuals – children to elderly people between 7 and 102 years old – of different age groups, most of them female (54.9%; n = 26,478). The year of publication ranged from 2010 to 2020, indicating that it is a recent theme, applied in almost all continents (America, Europe, Africa and Asia). The authors used data as continuous or into quantiles; blood pressure data also varied, with different cutoff points for the classification of arterial hypertension or continuously. The vast majority of studies have shown a positive association between VAI and blood pressure, both the sexes, in different age groups. The evaluation of the quality of the articles used by the Tool of the Joanna Briggs Institute according to their design.ConclusionIndividuals with increased VAI have higher blood pressure levels. Registration (PROSPERO: CRD42020205965).     

探究自拟清肝降压饮早期干预高血压前期和原发性1级高血压

目的观察分析自拟清肝降压饮早期干预高血压前期和原发性1级高血压的疗效。方法选取我院于2010年1月至2012年12月收治的高血压前期和原发性1级高血压患者100例进行临床研究。结果治疗后,辅助清肝降压饮治疗的观察组患者的血压控制有效率为93.3%,明显优于对照组(P<0.05);观察组患者的证候有效率为98.1%,明显高于对照组(P<0.05)。结论自拟清肝降压饮早期干预高血压前期和原发性1级高血压有着良好的治疗效果,可以在临床上广泛推广。     

Determinants of Brachial-Ankle Pulse Wave Velocity and Carotid-Femoral Pulse Wave Velocity in Healthy Koreans

The aim of this study was to determine the normal value of brachial-ankle pulse wave velocity (baPWV) and carotid-femoral pulse wave velocity (cfPWV) according to age group, gender, and the presence of cardiovascular risk factors in healthy Koreans, and to investigate the association between PWV and risk factors such as prehypertension, dyslipidemia, smoking, and obesity. We measured an arterial stiffness in 110 normal subjects who were 20 to 69 yr-old with no evidence of cardiovascular disease, cerebrovascular accident or diabetes mellitus. The mean values of baPWV and cfPWV were 12.6 (±2.27) m/sec (13.1±1.85 in men, 12.1±2.51 in women; P=0.019) and 8.70 (±1.99) m/sec (9.34±2.13 in men, 8.15±1.69 in women; P=0.001), respectively. The distribution of baPWV (P<0.001) and cfPWV (P=0.006) by age group and gender showed an increase in the mean value with age. Men had higher baPWV and cfPWV than women (P<0.001). There was a difference in baPWV and cfPWV by age group on prehypertension, dyslipidemia, current smoking, or obesity (P<0.001). In multiple linear regression, age and prehypertension were highly associated with baPWV and cfPWV after adjustment for confounding factors (P<0.001). The present study showed that baPWV and cfPWV are associated with age, gender, and prehypertension in healthy Koreans.

Graphical Abstract

相似文献   

老年血压正常高值耳鸣患者药物疗效分析

目的通过口服药物对老年血压正常高值伴耳鸣患者进行临床治疗,观察耳鸣疗效并分析可能影响因素。方法根据入选标准筛选上海市黄浦区五里桥街道社区卫生服务中心门诊诊断为老年血压正常高值且病程3个月及以上的耳鸣患者120例,给予松龄血脉康胶囊口服1．5g／次,3次／d,12d一个疗程,共服用2个疗程。疗程结束后根据疗效评定标准评价耳鸣疗效,观察治疗前后患者血压变化情况并分析疗效的相关因素。结果120例患者中,痊愈15例,显效31例,有效48例,无效26例;总有效率78．3％;经统计分析发现：疗效与耳鸣持续时间呈负相关,而年龄、耳鸣严重程度与疗效之间无统计学相关性;药物治疗后老年患者血压较治疗前有所下降,但差异无统计学意义。结论松龄血脉康胶囊治疗老年血压正常高值伴耳鸣患者有一定疗效,且对降低血压有积极作用。     

基于疾病风险分层的健康管理模式在中青年高血压前期患者中的应用效果

目的：探讨基于疾病风险分层的健康管理模式在中青年高血压前期患者中的应用效果。方法：选取中青年高血压前期患者256例,随机分为观察组和对照组各128例。对照组采用常规健康教育,观察组采用疾病风险分层的健康管理模式。结果：干预6个月后,观察组超重与肥胖、摄入盐过量、运动量不足、不合理膳食、饮酒情况均低于对照组,差异有统计学意义（P<0.05）;吸烟、心理问题情况比较差异无统计学意义（P>0.05）;在趋势性检验中,膳食不合理、饮酒比较差异有统计学意义（P<0.05）。干预3、6个月后,观察组自我健康管理行为各维度得分均高于对照组,且随时间改变呈增高趋势（P<0.001）;收缩压、舒张压均低于对照组,差异有统计学意义（P<0.05）,且随时间改变呈降低趋势（P<0.001）。结论：基于疾病风险分层的健康管理模式可有效改善中青年高血压前期患者的健康危险因素,促进自我健康管理行为的建立,从而降低血压水平。     

血脂水平对血压正常高值人群脉搏波传导速度的影响

目的 探讨血脂和脂蛋白比值对血压正常高值人群脉搏波传导速度的影响.方法 选择11 611名血压正常的健康体检者,分为正常血压值组(血压＜ 120/80 mmHg)和血压正常高值组(血压为120 ～ 139/80 ～ 89 mmHg).应用全自动动脉硬化仪测定人选者肱踝脉搏波传导速度(baPWV),同时测量身高、体重、FPG、TC、TG、HDL-C、LDL-C等指标,并计算HDL-C和TC/HDL-C比值、LDL-C/HDL-C比值.分析血脂和脂蛋白比值异常情况对不同血压组脉搏波传导速度的影响.结果 血压正常高值组的baPWV异常率均高于血压正常组.血压正常组中除HDL-C外,TC、TG、LDL-C、TC/HDL-C、LDL-C/HDL-C的升高均使baPWV的异常率显著增加(P＜0.001).血压正常高值组中,TC和LDL-C的升高使baPWV的异常率显著增加(P＜0.001).多元logistic回归分析显示,除年龄、BMI、FPG外,TC/HDL-C异常是血压正常组动脉僵硬度增高的独立危险因子(OR=1.732),TG异常是血压正常高值组的独立危险因素(OR=1.301).结论 在正常血压不同水平下,血脂和脂蛋白比值的异常是动脉僵硬度增高的独立危险因素.     

正常高值血压的流行病学及非药物治疗新进展

正常高值血压人群指的是血压范围在120～139 mm Hg/80～89 mm Hg(1 mm Hg=0.133 kPa)的人群.该人群罹患心血管疾病的风险较高.随着正常高值血压日益流行,一些降压的非药物于预措施应重新审视.本文对正常高值血压的流行病学及非药物治疗的研究结果及新进展综述如下.     

重视对正常血压高值人群的随访和治疗

流行病学研究显示血压从115／75mmHg起，心血管疾病（CVD）危险性随血压升高而增加；55岁时血压正常者未来发生高血压的危险为90％；为此JNC7提出了高血压前期的诊断，即120～139mmHg和／或80～89mmHg，建议改善生活方式以预防高血压的发生，并建议针对强适应证（心衰、心梗后、冠心病高危因素、糖尿病、慢性肾病以及预防中风复发）者选择药物降压治疗。我国流行病学研究也显示出同样的结果，中国高血压防治指南定义120～139／80～89mmHg为正常血压高值，并建议降低高血压发病率和CVD病死率应从正常血压高值人群中预防，近期开展的对正常血压高值是否应当降压治疗的讨论中，多数倾向于对正常血压高值人群应给予适当的治疗，包括非药物和药物治疗。     

高血压前期颈动脉内-中膜厚度及血管内皮舒张功能的变化

目的探索高血压前期外周动脉血管粥样硬化和血管内皮功能的改变。方法检测颈动脉内-中膜厚度（IMT）和肱动脉内皮舒张功能。结果高血压前期组颈动脉分叉、颈总动脉处内-中膜厚度均较正常血压组增厚（P〈0．05）;高血压前期组反应性充血后肱动脉内径变化率（FMD）显著低于正常血压组（P〈0．05）;含服硝酸甘油后肱动脉内径FMD高血压前期组与正常血压组无明显差异（P〉0．05）。结论高血压前期已存在颈动脉内-中膜增厚,血管内皮功能已经受损。